Notifications
Clear all
Topic starter
14/12/2018 10:37 pm
Drug repositioning of mevalonate pathway inhibitors as antitumor agents for ovarian cancer https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5641118/
Also read this https://www.cancertreatmentsresearch.com/bisphosphonates/ and this https://www.cancertreatmentsresearch.com/reduce-cholesterol-in-cancer-cells-to-fight-cancer/
